Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the safety of subcutaneous (SC) interferon beta therapies with regard to frequency of injection site reactions (ISR) and flu-like symptoms (FLS) as reported...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Biogen
Collaborators
NCT05359653 · Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, and more
NCT06390930 · Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, and more
NCT03401879 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
NCT06715436 · Multiple Sclerosis, Relapsing-Remitting
NCT06389968 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
Research Site
Göttingen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions